EZH2 and malignant colon neoplasm: c-Myc downregulation correlated with EZH2 inhibition in SW480 and with G9a inhibition in HCT116 cells, suggesting that the presence of wtp53 or mutp53 could influence the activity of KMTs in colon cancer cells.